Fasanara welcomes latest charity, Eyes on the Future, to Foundation

London, United Kingdom – October 18, 2023

Announcing our partnership with Eyes on the Future, a charity supporting those affected by rare eye diseases, fills us with an overwhelming sense of joy and purpose. Eyes on the Future joins Fasanara’s Foundation – Second Chances, a select group of charities which receive investors’ donated investment proceeds, matched by Fasanara who will donate the same percentage of their fees from that share class, via a special dedicated share class. They join a great list of existing charities already in our target list: United Hatzalah Israel Rescue, Stand By Me, and Synchronicity Earth.

Eyes on the Future represents a community focused on caring for individuals affected by Inherited Retinal Dystrophies (IRDs), a group of rare genetic eye diseases that cause progressive vision loss in children, and in particular those with RDH12 IRD, a gene mutation which causes severe retinal degeneration. Children affected by this condition unfortunately slowly lose their sight by their late-teens/early-twenties. The condition is currently untreatable. The community comprises RDH12 patients, caregivers, families and supporters, committed to driving research and treatment. By uniting patients, scientists, industry and stakeholders, they accelerate research efforts and work to bridge the gap between scientific progress and available treatments.

At Eyes on the Future, we believe in the power of unity and the resilience of the human spirit. Partnering with Fasanara is a step forward towards our shared goal of extending the gift of sight to those affected by inherited eye diseases.

- Silvia Cerolini, Co-Founder & CEO of Eyes on the Future, and mother of a 9 year old girl affected by this condition.

Eyes on the Future’s goal is to extend the duration of sight for affected individuals through awareness, scientific support and research advancement. They are firm believers in the power of collaboration across patients, industry and academia to make therapies accessible to those with RDH12 IRD and other inherited eye diseases. Further, they view their model of innovation as a potential solution for other rare diseases, given the shared challenges often faced.

We are overjoyed to have Eyes on the Future as part of our charity foundation. Together, we look forward to making a profound difference in the lives of many.

- Francesco Filia, Founder & CEO of Fasanara

If you would like to learn more about the efforts of Eyes on the Future, making a donation or to receive more information on Fasanara’s Foundation – Second Chances, do not hesitate to get in contact.

Useful links

For more information on Eyes on the Future, please visit: www.eyesonthefuture.org.uk

For more information on Fasanara’s Foundation – Second Chances, please visit: www.fasanara.com/charity

About Eyes on the Future

We are a community who care for people affected by Inherited Retinal Dystrophies (IRDs), specifically those affected by RDH12 IRD. We are RDH12 patients, carers, families and friends, united in our drive to find a treatment. We are the catalyst of focused efforts to find a cure for the condition, delivering tangible progress towards its resolution. We bring together patients, scientists, industries and stakeholders, accelerating research.

About Fasanara

Founded in 2011, Fasanara is a London-headquartered FCA-authorised investment firm and technology platform. We manage c. USD 4 billion in Fintech strategies on behalf of pension funds and insurance companies in Europe and North America, and a mandate from the European Investment Fund (EIF). With over 200 employees across five offices, we are a pioneer investor in Fintech Lending through our liquid Alternative Credit funds, enabling Real Economy Impact.